Related Experiment Video
Updated: Jan 28, 2026

Electroactive Polymer Nanoparticles Exhibiting Photothermal Properties
Published on: January 8, 2016
Prostate-specific membrane antigen targeted organic semiconducting polymer nanoparticles for enhanced photothermal
Zhongji Jiang1,2, Xun Zhang3, Gaohaer Kadeerhan4
1School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Abstract:
Photothermal therapy (PTT) in the second near-infrared window (NIR-II, 1000-1700 nm) enables deep-tissue penetration and reduced off-target damage, offering a promising approach for localized cancer ablation. A major challenge, however, lies in achieving efficient and tumor-specific accumulation of photothermal agents. In this study, we developed a prostate-specific membrane antigen (PSMA)-targeted NIR-II photothermal nanoplatform based on an organic semiconducting polymer (OSP12). The OSP12 core was encapsulated with DSPE-PEG-Mal and covalently conjugated with ACUPA, a high-affinity PSMA ligand, to generate PSMA-OSP12 nanoparticles (NPs). These nanoparticles exhibited strong NIR-II fluorescence emission and high photothermal conversion efficiency under 808 nm excitation; notably, at 1.0 W/cm2 for 5 min the maximum solution temperature reached 77.3°C, and the particles showed excellent photothermal stability, retaining >90.0% of their peak heating performance after five on/off irradiation cycles. Owing to their enhanced targeting capability and robust photothermal stability, PSMA-OSP12 NPs enabled effective photothermal ablation of PSMA-positive prostate tumors with minimal systemic toxicity in vivo. Collectively, our findings demonstrate that PSMA-OSP12 NPs constitute a potent and precise NIR-II photothermal nanoplatform for prostate cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Polymers
Polymers
Organic Compounds
Gene Therapy

